ArticleEye (London, England)2025

Treatment intervals with first-generation anti-vascular endothelial growth factor drugs: evaluating the unmet need in a real-world neovascular age-related macular degeneration national database.

Javier Zarranz-Ventura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.